Targeted protein degraders crowd into the clinic

At least 15 targeted degraders — from heterobifunctional PROTACs to molecular glues — should be in patients by the end of the year. At least 15 targeted degraders — from heterobifunctional PROTACs to molecular glues — should be in patients by the end of the year.